Alzheimer's disease and the fornix

Frontiers in Aging Neuroscience

Volumn 6, Issue SEP, 2014, Pages

  Oishi, Kenichi ^a   Lyketsos, Constantine G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Deep brain stimulation; Diffusion tensor imaging; Fornix; Limbic system; Magnetic resonance imaging; Mild cognitive impairment; White matter

Indexed keywords

ALZHEIMER DISEASE; BRAIN FORNIX; CEREBROSPINAL FLUID; DEGENERATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; SHORT SURVEY;

EID: 84907163439     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00241     Document Type: Short Survey

References (101)

1. Acosta-Cabronero, J., Williams, G. B., Pengas, G., and Nestor, P. J. (2010). Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 133, 529-539. doi: 10.1093/brain/awp257
2. Agosta, F., Pievani, M., Sala, S., Geroldi, C., Galluzzi, S., Frisoni, G. B., et al. (2011). White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 258, 853-863. doi: 10.1148/radiol.10101284
3. Alexander, A. L., Hasan, K. M., Lazar, M., Tsuruda, J. S., and Parker, D. L. (2001). Analysis of partial volume effects in diffusion-tensor MRI. Magn. Reson. Med. 45, 770-780. doi: 10.1002/mrm.1105
4. Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K. (1994). Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl. Acad. Sci. U S A 91, 5562-5566. doi: 10.1016/0197-4580(94)92603-4
5. Ashburner, J., and Kloppel, S. (2011). Multivariate models of inter-subject anatomical variability. Neuroimage. 56, 422-439. doi: 10.1016/j.neuroimage.2010.03.059
6. Back, S. A., Kroenke, C. D., Sherman, L. S., Lawrence, G., Gong, X., Taber, E. N., et al. (2011). White matter lesions defined by diffusion tensor imaging in older adults. Ann. Neurol. 70, 465-476. doi: 10.1002/ana.22484
7. Balthazar, M. L., Yasuda, C. L., Pereira, F. R., Pedro, T., Damasceno, B. P., and Cendes, F. (2009). Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer's disease. Eur. J. Neurol. 16, 468-474. doi: 10.1111/j.1468-1331.2008.02408.x
8. Berlot, R., Metzler-Baddeley, C., Jones, D. K., and O'sullivan, M. J. (2014). CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment. Neuroimage 92, 27-35. doi: 10.1016/j.neuroimage.2014.01.031
9. Bosch, B., Arenaza-Urquijo, E. M., Rami, L., Sala-Llonch, R., Junque´, C., Sole´-Padulle´s, C., et al. (2010). Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol. Aging 33, 61-74. doi: 10.1016/j.neurobiolaging.2010.02.004
10. Bossy-Wetzel, E., Schwarzenbacher, R., and Lipton, S. A. (2004). Molecular pathways to neurodegeneration. Nat. Med. 10(Suppl.), S2-S9. doi: 10.1038/nm1067
11. Braak, H., and Braak, E. (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16, 271-278; discussion 278-284. doi: 10.1016/0197-4580(95)00021-6
12. Bramblett, G. T., Trojanowski, J. Q., and Lee, V. M. (1992). Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Lab. Invest. 66, 212-222.
13. Brun, A., and Englund, E. (1986). A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 19, 253-262. doi: 10.1002/ana.410190306
14. Bunce, J. G., Sabolek, H. R., and Chrobak, J. J. (2003). Intraseptal infusion of oxotremorine impairs memory in a delayed-non-match-to-sample radial maze task. Neuroscience 121, 259-267. doi: 10.1016/s0306-4522(03)00462-7
15. Callen, D. J., Black, S. E., Gao, F., Caldwell, C. B., and Szalai, J. P. (2001). Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 57, 1669-1674. doi: 10.1212/wnl.57.9.1669
16. Chalmers, K., Wilcock, G., and Love, S. (2005). Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 31, 623-631. doi: 10.1111/j.1365-2990.2005.00678.x
17. Chevalier-Larsen, E., and Holzbaur, E. L. (2006). Axonal transport and neurodegenerative disease. Biochim. Biophys. Acta 1762, 1094-1108. doi: 10.1016/j.bbadis.2006.04.002
18. Coleman, M. (2005). Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6, 889-898. doi: 10.1038/nrn1788
19. Colom, L. V., Castañeda, M. T., Bañuelos, C., Puras, G., Garci´a-Herna´ndez, A., Hernandez, S., et al. (2010). Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function. Neurobiol. Aging 31, 46-57. doi: 10.1016/j.neurobiolaging.2008.05.006
20. Copenhaver, B. R., Rabin, L. A., Saykin, A. J., Roth, R. M., Wishart, H. A., Flashman, L. A., et al. (2006). The fornix and mammillary bodies in older adults with Alzheimer's disease, mild cognitive impairment and cognitive complaints: a volumetric MRI study. Psychiatry Res. 147, 93-103. doi: 10.1016/j.pscychresns.2006.01.015
21. Damoiseaux, J. S., Smith, S. M., Witter, M. P., Sanz-Arigita, E. J., Barkhof, F., Scheltens, P., et al. (2009). White matter tract integrity in aging and Alzheimer's disease. Hum. Brain Mapp. 30, 1051-1059. doi: 10.1002/hbm.20563
22. Dawson, H. N., Cantillana, V., Jansen, M., Wang, H., Vitek, M. P., Wilcock, D. M., et al. (2010). Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease. Neuroscience 169, 516-531. doi: 10.1016/j.neuroscience.2010.04.037
23. de la Monte, S. M. (1989). Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann. Neurol. 25, 450-459. doi: 10.1002/ana.410250506
24. Delatour, B., Gue´gan, M., Volk, A., and Dhenain, M. (2006). In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol. Aging 27, 835-847. doi: 10.1016/j.neurobiolaging.2005.04.011
25. Douaud, G., Menke, R. A., Gass, A., Monsch, A. U., Rao, A., Whitcher, B., et al. (2013). Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease. J. Neurosci. 33, 2147-2155. doi: 10.1523/jneurosci.4437-12.2013
26. Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., and Mandelkow, E. (1998). Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol. 143, 777-794. doi: 10.1083/jcb.143.3.777
27. Englund, E., Brun, A., and Alling, C. (1988). White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 111(Pt. 6), 1425-1439. doi: 10.1093/brain/111.6.1425
28. Firbank, M. J., Blamire, A. M., Teodorczuk, A., Teper, E., Mitra, D., and O'brien, J. T. (2011). Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies. Psychiatry Res. 194, 176-183. doi: 10.1016/j.pscychresns.2011.08.002
29. Fletcher, E., Carmichael, O., Pasternak, O., Maier-Hein, K. H., and Decarli, C. (2014). Early brain loss in circuits affected by Alzheimer's disease is predicted by fornix microstructure but may be independent of gray matter. Front. Aging Neurosci. 6:106. doi: 10.3389/fnagi.2014.00106
30. Fletcher, E., Raman, M., Huebner, P., Liu, A., Mungas, D., Carmichael, O., et al. (2013). Loss of fornix white matter volume as a predictor of cognitive impairment in cognitively normal elderly individuals. JAMA Neurol. 70, 1389-1395. doi: 10.1001/jamaneurol.2013.3263
31. Gonzalez-Lima, F., Berndt, J. D., Valla, J. E., Games, D., and Reiman, E. M. (2001). Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. Neuroreport 12, 2375-2379. doi: 10.1097/00001756-200108080-00018
32. Gunawardena, S., and Goldstein, L. S. (2001). Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389-401. doi: 10.1016/s0896-6273(01)00496-2
33. Guo, X., Wang, Z., Li, K., Li, Z., Qi, Z., Jin, Z., et al. (2010). Voxel-based assessment of gray and white matter volumes in Alzheimer's disease. Neurosci. Lett. 468, 146-150. doi: 10.1016/j.neulet.2009.10.086
34. Haglund, M., and Englund, E. (2002). Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment. Dement. Geriatr. Cogn. Disord. 14, 161-166. doi: 10.1159/000063606
35. Hamani, C., Mcandrews, M. P., Cohn, M., Oh, M., Zumsteg, D., Shapiro, C. M., et al. (2008). Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann. Neurol. 63, 119-123. doi: 10.1002/ana.21295
36. Hamani, C., Stone, S. S., Garten, A., Lozano, A. M., and Winocur, G. (2011). Memory rescue and enhanced neurogenesis following electrical stimulation of the anterior thalamus in rats treated with corticosterone. Exp. Neurol. 232, 100-104. doi: 10.1016/j.expneurol.2011.08.023
37. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
38. Hattori, T., Ito, K., Aoki, S., Yuasa, T., Sato, R., Ishikawa, M., et al. (2012). White matter alteration in idiopathic normal pressure hydrocephalus: tract-based spatial statistics study. AJNR Am. J. Neuroradiol. 33, 97-103. doi: 10.3174/ajnr.a2706
39. Head, D., Buckner, R. L., Shimony, J. S., Williams, L. E., Akbudak, E., Conturo, T. E., et al. (2004). Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. Cereb. Cortex 14, 410-423. doi: 10.1093/cercor/bhh003
40. Honea, R. A., Vidoni, E., Harsha, A., and Burns, J. M. (2009). Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J. Alzheimers Dis. 18, 553-564. doi: 10.3233/JAD-2009-1163
41. Hopper, M. W., and Vogel, F. S. (1976). The limbic system in Alzheimer's disease. A neuropathologic investigation. Am. J. Pathol. 85, 1-20.
42. Hornberger, M., Wong, S., Tan, R., Irish, M., Piguet, O., Kril, J., et al. (2012). In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease. Brain 135, 3015-3025. doi: 10.1093/brain/aws239
43. Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128. doi: 10.1016/s1474-4422(09)70299-6
44. Kantarci, K., Avula, R., Senjem, M. L., Samikoglu, A. R., Zhang, B., Weigand, S. D., et al. (2010). Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 74, 1814-1821. doi: 10.1212/wnl.0b013e3181e0f7cf
45. Kantarci, K., Jack, C. R. Jr., Xu, Y. C., Campeau, N. G., O'brien, P. C., Smith, G. E., et al. (2001). Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology 219, 101-107. doi: 10.1148/radiology.219.1.r01ap14101
46. Kwong, K. K., Mckinstry, R. C., Chien, D., Crawley, A. P., Pearlman, J. D., and Rosen, B. R. (1991). CSF-suppressed quantitative single-shot diffusion imaging. Magn. Reson. Med. 21, 157-163. doi: 10.1002/mrm.1910210120
47. Landhuis, E. (2013). Fornix First-Atrophy Foreshadows Decline in Normal Aging? Available online at: http://www.alzforum.org/news/research-news/fornix-first-atrophy-foreshadows-decline-normal-aging. Accessed on June 19 2014.
48. Laxton, A. W., Tang-Wai, D. F., Mcandrews, M. P., Zumsteg, D., Wennberg, R., Keren, R., et al. (2010). A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann. Neurol. 68, 521-534. doi: 10.1002/ana.22089
49. Lee, J. T., Xu, J., Lee, J. M., Ku, G., Han, X., Yang, D. I., et al. (2004). Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164, 123-131. doi: 10.1083/jcb.200307017
50. Li, S., Pu, F., Shi, F., Xie, S., Wang, Y., and Jiang, T. (2008). Regional white matter decreases in Alzheimer's disease using optimized voxel-based morphometry. Acta Radiol. 49, 84-90. doi: 10.1080/02841850701627181
51. Liu, Y., Spulber, G., Lehtima¨ki, K. K., Ko¨no¨nen, M., Hallikainen, I., Gro¨hn, H., et al. (2011). Diffusion tensor imaging and tract-based spatial statistics in Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 32, 1558-1571. doi: 10.1016/j.neurobiolaging.2009.10.006
52. Lue, L. F., Kuo, Y. M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., et al. (1999). Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862. doi: 10.1016/s0002-9440(10)65184-x
53. Lyketsos, C. G., Targum, S. D., Pendergrass, J. C., and Lozano, A. M. (2012). Deep brain stimulation: a novel strategy for treating Alzheimer's disease. Innov. Clin. Neurosci. 9, 10-17.
54. Maheswaran, S., Barjat, H., Rueckert, D., Bate, S. T., Howlett, D. R., Tilling, L., et al. (2009). Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI. Brain Res. 1270, 19-32. doi: 10.1016/j.brainres.2009.02.045
55. Medina, D., Detoledo-Morrell, L., Urresta, F., Gabrieli, J. D., Moseley, M., Fleischman, D., et al. (2006). White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol. Aging 27, 663-672. doi: 10.1016/j.neurobiolaging.2005.03.026
56. Mehraein, P., and Rothemund, E. (1976). [Neuroanatomical correlates of the amnestic syndrome (author's transl)]. Arch. Psychiatr. Nervenkr. 222, 153-176.
57. Metzler-Baddeley, C., O'sullivan, M. J., Bells, S., Pasternak, O., and Jones, D. K. (2012). How and how not to correct for CSF-contamination in diffusion MRI. Neuroimage 59, 1394-1403. doi: 10.1016/j.neuroimage.2011.08.043
58. Mielke, M. M., Kozauer, N. A., Chan, K. C., George, M., Toroney, J., Zerrate, M., et al. (2009). Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 46, 47-55. doi: 10.1016/j.neuroimage.2009.01.054
59. Mielke, M. M., Okonkwo, O. C., Oishi, K., Mori, S., Tighe, S., Miller, M. I., et al. (2012). Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimers Dement. 8, 105-113. doi: 10.1016/j.jalz.2011.05.2416
60. Milner, T. A., and Amaral, D. G. (1984). Evidence for a ventral septal projection to the hippocampal formation of the rat. Exp. Brain Res. 55, 579-585. doi: 10.1007/bf00235290
61. Molino, I., Cavaliere, C., Salvatore, E., Quarantelli, M., Colucci, L., and Fasanaro, A. M. (2014). Is anterior communicating artery syndrome related to fornix lesions? J. Alzheimers Dis. 42, S199-S204. doi: 10.3233/JAD-132648
62. Oertel-Kno¨chel, V., Reinke, B., Alves, G., Jurcoane, A., Wenzler, S., Prvulovic, D., et al. (2014). Frontal white matter alterations are associated with executive cognitive function in euthymic bipolar patients. J. Affect. Disord. 155, 223-233. doi: 10.1016/j.jad.2013.11.004
63. Oishi, K., Akhter, K., Mielke, M., Ceritoglu, C., Zhang, J., Jiang, H., et al. (2011a). Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front. Neurol. 2:54. doi: 10.3389/fneur.2011.00054
64. Oishi, K., Faria, A., Jiang, H., Li, X., Akhter, K., Zhang, J., et al. (2009). Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participantstlas. Neuroimage 46, 486-499. doi: 10.1016/j.neuroimage.2009.01.002
65. Oishi, K., Mielke, M. M., Albert, M., Lyketsos, C. G., and Mori, S. (2011b). DTI analyses and clinical applications in Alzheimer's disease. J. Alzheimers Dis. 26(Suppl. 3), 287-296. doi: 10.3233/JAD-2011-0007
66. Oishi, K., Mielke, M. M., Albert, M., Lyketsos, C. G., and Mori, S. (2012). The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. J. Neuroimaging 22, 365-374. doi: 10.1111/j.1552-6569.2011.00633.x
67. Pasternak, O., Sochen, N., Gur, Y., Intrator, N., and Assaf, Y. (2009). Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 62, 717-730. doi: 10.1002/mrm.22055
68. Pfefferbaum, A., and Sullivan, E. V. (2003). Increased brain white matter diffusivity in normal adult aging: relationship to anisotropy and partial voluming. Magn. Reson. Med. 49, 953-961. doi: 10.1002/mrm.10452
69. Pigino, G., Morfini, G., Pelsman, A., Mattson, M. P., Brady, S. T., and Busciglio, J. (2003). Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23, 4499-4508.
70. Ransmayr, G., Cervera, P., Hirsch, E., Ruberg, M., Hersh, L. B., Duyckaerts, C., et al. (1989). Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease. Neuroscience 32, 701-714. doi: 10.1016/0306-4522(89)90291-1
71. Ringman, J. M., O'neill, J., Geschwind, D., Medina, L., Apostolova, L. G., Rodriguez, Y., et al. (2007). Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 130, 1767-1776. doi: 10.1093/brain/awm102
72. Roher, A. E., Weiss, N., Kokjohn, T. A., Kuo, Y. M., Kalback, W., Anthony, J., et al. (2002). Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 41, 11080-11090. doi: 10.1021/bi026173d
73. Rohrer, J. D., Lashley, T., Schott, J. M., Warren, J. E., Mead, S., Isaacs, A. M., et al. (2011). Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 134, 2565-2581. doi: 10.1093/brain/awr198
74. Rose, S. E., Chen, F., Chalk, J. B., Zelaya, F. O., Strugnell, W. E., Benson, M., et al. (2000). Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J. Neurol. Neurosurg. Psychiatry 69, 528-530. doi: 10.1136/jnnp.69.4.528
75. Sachdev, P. S., Zhuang, L., Braidy, N., and Wen, W. (2013). Is Alzheimer's a disease of the white matter? Curr. Opin. Psychiatry 26, 244-251. doi: 10.1097/YCO.0b013e32835ed6e8
76. Salat, D. H., Tuch, D. S., Van Der Kouwe, A. J., Greve, D. N., Pappu, V., Lee, S. Y., et al. (2010). White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol. Aging 31, 244-256. doi: 10.1016/j.neurobiolaging.2008.03.013
77. Sara, S. J. (1989). Noradrenergic-cholinergic interaction: its possible role in memory dysfunction associated with senile dementia. Arch. Gerontol. Geriatr. Suppl. 1, 99-108.
78. Schegg, K. M., Nielsen, S., Zweig, R. M., and Peacock, J. H. (1989). Decrease in membrane-bound G4 form of acetylcholinesterase in postmortem Alzheimer brain. Prog. Clin. Biol. Res. 317, 437-452.
79. Serra, L., Cercignani, M., Lenzi, D., Perri, R., Fadda, L., Caltagirone, C., et al. (2010). Grey and white matter changes at different stages of Alzheimer's disease. J. Alzheimers Dis. 19, 147-159. doi: 10.3233/JAD-2010-1223
80. Sexton, C. E., Kalu, U. G., Filippini, N., Mackay, C. E., and Ebmeier, K. P. (2011). A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 32, 2322.e5-2322.e18. doi: 10.1016/j.neurobiolaging.2010.05.019
81. Smith, C. D., Chebrolu, H., Andersen, A. H., Powell, D. A., Lovell, M. A., Xiong, S., et al. (2010). White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol. Aging 31, 1122-1131. doi: 10.1016/j.neurobiolaging.2008.08.006
82. Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., et al. (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31, 1487-1505. doi: 10.1016/j.neuroimage.2006.02.024
83. Smith, G. S., Laxton, A. W., Tang-Wai, D. F., Mcandrews, M. P., Diaconescu, A. O., Workman, C. I., et al. (2012). Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease. Arch. Neurol. 69, 1141-1148. doi: 10.1001/archneurol.2012.590
84. Stahl, R., Dietrich, O., Teipel, S. J., Hampel, H., Reiser, M. F., and Schoenberg, S. O. (2007). White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 243, 483-492. doi: 10.1148/radiol.2432051714
85. Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., et al. (2005). Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282-1288. doi: 10.1126/science.1105681
86. Stricker, N. H., Schweinsburg, B. C., Delano-Wood, L., Wierenga, C. E., Bangen, K. J., Haaland, K. Y., et al. (2009). Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage 45, 10-16. doi: 10.1016/j.neuroimage.2008.11.027
87. Tang, X., Yoshida, S., Hsu, J., Huisman, T. A., Faria, A. V., Oishi, K., et al. (2014). Multi-contrast multi-atlas parcellation of diffusion tensor imaging of the human brain. PLoS One 9:e96985. doi: 10.1371/journal.pone.0096985
88. Teipel, S. J., Stahl, R., Dietrich, O., Schoenberg, S. O., Perneczky, R., Bokde, A. L., et al. (2007). Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage 34, 985-995. doi: 10.1016/j.neuroimage.2006.07.047
89. Thomas, A. G., Koumellis, P., and Dineen, R. A. (2011). The fornix in health and disease: an imaging review. Radiographics 31, 1107-1121. doi: 10.1148/rg.314105729
90. Toda, H., Hamani, C., Fawcett, A. P., Hutchison, W. D., and Lozano, A. M. (2008). The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. J. Neurosurg. 108, 132-138. doi: 10.3171/jns/2008/108/01/0132
91. Vos, S. B., Jones, D. K., Viergever, M. A., and Leemans, A. (2011). Partial volume effect as a hidden covariate in DTI analyses. Neuroimage 55, 1566-1576. doi: 10.1016/j.neuroimage.2011.01.048
92. Wenk, G., Hughey, D., Boundy, V., Kim, A., Walker, L., and Olton, D. (1987). Neurotransmitters and memory: role of cholinergic, serotonergic and noradrenergic systems. Behav. Neurosci. 101, 325-332. doi: 10.1037//0735-7044.101.3.325
93. Wu, M., Rosano, C., Lopez-Garcia, P., Carter, C. S., and Aizenstein, H. J. (2007). Optimum template selection for atlas-based segmentation. Neuroimage 34, 1612-1618. doi: 10.1016/j.neuroimage.2006.07.050
94. Xie, S., Xiao, J. X., Gong, G. L., Zang, Y. F., Wang, Y. H., Wu, H. K., et al. (2006). Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 66, 1845-1849. doi: 10.1212/01.wnl.0000219625.77625.aa
95. Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., et al. (2001). Amyloid-beta peptides are cytotoxic to oligodendrocytes. J. Neurosci. 21:RC118.
96. Yamamoto, T., Kurobe, H., Kawamura, J., Hashimoto, S., and Nakamura, M. (1990). Subacute dementia with necrotising encephalitis selectively involving the fornix and splenium. Retrograde development of Alzheimer's neurofibrillar tangles in the subiculum. J. Neurol. Sci. 96, 159-172. doi: 10.1016/0022-510x(90)90129-b
97. Yoon, B., Shim, Y. S., Hong, Y. J., Koo, B. B., Kim, Y. D., Lee, K. O., et al. (2011). Comparison of diffusion tensor imaging and voxel-based morphometry to detect white matter damage in Alzheimer's disease. J. Neurol. Sci. 302, 89-95. doi: 10.1016/j.jns.2010.11.012
98. Zarei, M., Damoiseaux, J. S., Morgese, C., Beckmann, C. F., Smith, S. M., Matthews, P. M., et al. (2009). Regional white matter integrity differentiates between vascular dementia and Alzheimer disease. Stroke 40, 773-779. doi: 10.1161/strokeaha.108.530832
99. Zhang, Y., Schuff, N., Du, A. T., Rosen, H. J., Kramer, J. H., Gorno-Tempini, M. L., et al. (2009). White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 132, 2579-2592. doi: 10.1093/brain/awp071
100. Zhang, Y., Schuff, N., Jahng, G. H., Bayne, W., Mori, S., Schad, L., et al. (2007). Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 68, 13-19. doi: 10.1212/01.wnl.0000250326.77323.01
101. Zhou, Y., Dougherty, J. H. Jr., Hubner, K. F., Bai, B., Cannon, R. L., and Hutson, R. K. (2008). Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment. Alzheimers Dement. 4, 265-270. doi: 10.1016/j.jalz.2008.04.006